A study to determine lipid changing effects of MK0524A when compared to niacin extended release (NIASPAN) and placebo.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
407
To assess the HDL-C raising efficacy of MK-0524A when compared with niacin extended release (NIASPAN) and placebo.
Time frame: After 4 weeks
To asses the triglyceride-lowering effects of MK-0524A when compared with niacin extended release (NIASPAN) and placebo.
Time frame: After 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.